A study involving identical twins suggests alterations in immune cells called CD8 T-cells may be early drivers of ...

SetPoint plans to launch a trial of its implant device, stimulating the vagus nerve to promote myelin repair, next year in ...

The Foundation of the Consortium of Multiple Sclerosis Centers (FCMSC) was gifted $100,000 by EMD Serono for its nursing scholarship fund.

Plasma exchange therapy is effective for severe relapses in MS patients who respond inadequately to standard corticosteroids, ...

Plasma exchange (PLEX) therapy is effective for severe relapses in people with multiple sclerosis (MS) who respond inadequately to standard corticosteroid therapy, according to a new study ...

A sublingual formulation of cladribine showed comparable pharmacological properties to its name brand counterpart, Mavenclad.

I drive a wheelchair now. Mine tilts and reclines, so it’s a bit heavier than most. It’s not a car, but there’s a certain amount of responsibility that goes with it because like any vehicle, it too is ...

A sublingual formulation of cladribine, which is the active ingredient of the approved oral treatment Mavenclad, in relapsing multiple sclerosis (MS), showed comparable pharmacological properties ...

Anti-CD20 therapies like Ocrevus and rituximab may be ineffective at slowing disability progression in PPMS patients, per a ...